Stefan Guldin University College London
At present, drug dosage is based on standardised approaches that disregard pharmakokinetic differences between patients and lead to non-optimal efficacy and unnecessary side effects. In this work, we demonstrate the potential of pH-mediated fluorescence spectroscopy for therapeutic drug monitoring in complex media. We apply this principle to the simultaneous quantification of the chemotherapeutic prodrug Irinotecan and its active metabolite SN-38 from human plasma across the clinically relevant concentration range, i.e. from micromolar to nanomolar at molar ratios of up to 30:1.
download asset Serranoetal_QIRSN38_ChemRxiv_v1.pdf 0.44 MB [opens in a new tab] cloud_download
pdf : 0.44 MB
download asset Serranoetal_QIRSN38_ESI_ChemRxiv_v1.pdf 0.73 MB [opens in a new tab] cloud_download
pdf : 0.73 MB
Serrano et al QIRSN38 ESI ChemRxiv v1